204 related articles for article (PubMed ID: 28753992)
1. Applicability of Metal Nanoparticles in the Detection and Monitoring of Hepatitis B Virus Infection.
Shevtsov M; Zhao L; Protzer U; van de Klundert MAA
Viruses; 2017 Jul; 9(7):. PubMed ID: 28753992
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
[TBL] [Abstract][Full Text] [Related]
3. Role of occult hepatitis B virus infection in chronic hepatitis C.
Coppola N; Onorato L; Pisaturo M; Macera M; Sagnelli C; Martini S; Sagnelli E
World J Gastroenterol; 2015 Nov; 21(42):11931-40. PubMed ID: 26576082
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticles and hepatitis B virus.
Negahdari B; Darvishi M; Saeedi AA
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):469-474. PubMed ID: 30686057
[TBL] [Abstract][Full Text] [Related]
5. Gold nanoparticles and hepatitis B virus.
Negahdari B; Darvishi M; Saeedi AA
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):455-461. PubMed ID: 30836779
[TBL] [Abstract][Full Text] [Related]
6. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study.
Park YM; Lee SG
World J Gastroenterol; 2016 Nov; 22(44):9836-9843. PubMed ID: 27956808
[TBL] [Abstract][Full Text] [Related]
8. A novel method for sensitive, low-cost and portable detection of hepatitis B surface antigen using a personal glucose meter.
Taebi S; Keyhanfar M; Noorbakhsh A
J Immunol Methods; 2018 Jul; 458():26-32. PubMed ID: 29654816
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
[TBL] [Abstract][Full Text] [Related]
11. [Occult hepatitis B infection].
Ergünay K
Mikrobiyol Bul; 2005 Apr; 39(2):241-9. PubMed ID: 16128037
[TBL] [Abstract][Full Text] [Related]
12. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
[TBL] [Abstract][Full Text] [Related]
13. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
14. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
[TBL] [Abstract][Full Text] [Related]
16. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
17. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
Hsia CC; Scudamore CH; Di Bisceglie AM; Tabor E
J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
[TBL] [Abstract][Full Text] [Related]
18. Natural history of chronic hepatitis B: what exactly has REVEAL revealed?
Iloeje UH; Yang HI; Chen CJ
Liver Int; 2012 Oct; 32(9):1333-41. PubMed ID: 22510145
[TBL] [Abstract][Full Text] [Related]
19. [Nested polymerase chain reaction (PCR) and multiple cloned antibody capture PCR for the examination of serum hepatitis B virus DNA in negative hepatitis B surface antigen patients suffering from liver diseases].
He J; Wu J; Du S
Zhonghua Nei Ke Za Zhi; 1996 Aug; 35(8):537-41. PubMed ID: 9594146
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study.
Obika M; Shinji T; Fujioka S; Terada R; Ryuko H; Lwin AA; Shiraha H; Koide N
Intervirology; 2008; 51(1):59-68. PubMed ID: 18349544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]